Investment Focus Malin Corporation is a life sciences investment company headquartered in Ireland and listed on Euronext Growth Dublin, concentrating on providing long-term capital and strategic support to innovative investee companies to accelerate value creation and patient outcomes.

Portfolio Collaboration Recent activity includes a collaboration and licensing deal between Poseida Therapeutics (an investee) and Xyphos Biosciences to develop CAR-T therapies for solid tumors, signaling opportunities for collaboration, licensing, and co-development deals with Malin’s network.

Technology Stack Malin operates using cloud-based and web technologies (AWS, CloudFlare, PHP, MySQL, Bootstrap) indicating potential needs for IT services, secure data infra, and modernization or integration support for portfolio companies.

Financial Position Revenue is below one million with total funding of around fifty-six million, suggesting a focus on scalable, cost-conscious technology platforms and potential for services in early-stage portfolio companies seeking capital-efficient growth.

Market Position As a Dublin-listed life sciences investor with a history of leadership changes and industry recognition, Malin presents opportunities for targeted deal sourcing, value-add partnerships, and strategic advisory services to accelerate portfolio exits and shareholder value.